Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.35 USD
−35.33 M USD
991.47 K USD
30.21 M
About Co-Diagnostics, Inc.
Sector
Industry
CEO
Dwight Howard Egan
Website
Headquarters
Salt Lake City
Founded
2013
FIGI
BBG004HTR2D1
Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests. The company was founded by Brent C. Satterfield and Dwight Howard Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of CODX is 1.01 USD — it has decreased by −4.72% in the past 24 hours. Watch Co-Diagnostics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Co-Diagnostics, Inc. stocks are traded under the ticker CODX.
CODX stock has fallen by −8.18% compared to the previous week, the month change is a −19.84% fall, over the last year Co-Diagnostics, Inc. has showed a −27.86% decrease.
We've gathered analysts' opinions on Co-Diagnostics, Inc. future price: according to them, CODX price has a max estimate of 1.50 USD and a min estimate of 1.50 USD. Watch CODX chart and read a more detailed Co-Diagnostics, Inc. stock forecast: see what analysts think of Co-Diagnostics, Inc. and suggest that you do with its stocks.
CODX reached its all-time high on Aug 3, 2020 with the price of 30.99 USD, and its all-time low was 0.69 USD and was reached on Jun 5, 2019. View more price dynamics on CODX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CODX stock is 6.00% volatile and has beta coefficient of 1.34. Track Co-Diagnostics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Co-Diagnostics, Inc. there?
Yes, you can track Co-Diagnostics, Inc. financials in yearly and quarterly reports right on TradingView.
Co-Diagnostics, Inc. is going to release the next earnings report on Apr 8, 2025. Keep track of upcoming events with our Earnings Calendar.
CODX earnings for the last quarter are −0.32 USD per share, whereas the estimation was −0.33 USD resulting in a 3.03% surprise. The estimated earnings for the next quarter are −0.34 USD per share. See more details about Co-Diagnostics, Inc. earnings.
Co-Diagnostics, Inc. revenue for the last quarter amounts to 641.14 K USD, despite the estimated figure of 375.00 K USD. In the next quarter, revenue is expected to reach 375.00 K USD.
CODX net income for the last quarter is −9.70 M USD, while the quarter before that showed −7.60 M USD of net income which accounts for −27.60% change. Track more Co-Diagnostics, Inc. financial stats to get the full picture.
No, CODX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 24, 2024, the company has 155.00 employees. See our rating of the largest employees — is Co-Diagnostics, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Co-Diagnostics, Inc. EBITDA is −41.81 M USD, and current EBITDA margin is −4.77 K%. See more stats in Co-Diagnostics, Inc. financial statements.
Like other stocks, CODX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Co-Diagnostics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Co-Diagnostics, Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Co-Diagnostics, Inc. stock shows the sell signal. See more of Co-Diagnostics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.